Six-Month Preclinical Evaluation of a Bilayered ePTFE Glaucoma Implant in Normotensive Rabbits
5 affiliations
- 1Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
- 2Crandall Center for Glaucoma Innovation, University of Utah, Salt Lake City, UT, USA
- 3Veranex, Raleigh, NC, USA
- 4W.L. Gore and Associates, Elkton, MD, USA
- 5Prism Eye Institute, Toronto, Ontario, Canada
Abstract
Purpose: The efficacy of intraocular pressure (IOP)-lowering glaucoma surgery is limited by postoperative fibrosis. A bilayered expanded polytetrafluoroethylene (ePTFE) implant reduced fibrosis compared with silicone controls in a three-month study in normotensive rabbit eyes. Here, we evaluate biocompatibility and histopathology over six months.
Methods: Twelve normotensive New Zealand white rabbits underwent bilayered ePTFE implantation in one eye and a sham procedure in the fellow eye. Clinical exams were monitored serially over six months and graded, including gross inspection, slit-lamp biomicroscopy, bleb evaluation, IOP measurement, and fundus examination. After six months, histopathologic analysis was performed on six eyes and graded for cellular integration, fibrosis, and inflammation.
Results: The implant was well tolerated. No significant differences in conjunctival hyperemia or bleb vascularity were observed between implant and sham eyes; however, tube position was closer to the cornea at six months. In implanted eyes, IOP was reduced at postoperative day 1 (12.4 ± 1.6 mm Hg, P = 0.001), week 1 (12.7 ± 1.9 mm Hg, P = 0.006), week 2 (12.9 ± 2.0 mm Hg, P = 0.002), month 1 (13.1 ± 1.5 mm Hg, P = 0.01), and month 3 (14.1 ± 2.1 mm Hg, P = 0.04) versus baseline (16.5 ± 2.9 mm Hg). Sham eyes showed reductions at day 3 and week 2. Histopathology demonstrated cellular integration into the outer ePTFE layer, with minimal inflammation (0.9 ± 1) and fibrosis (1.1 ± 0.2).
Conclusions: A bilayered ePTFE glaucoma implant was well tolerated for six months, with minimal inflammation or fibrosis.
Translational Relevance: A low-profile, bilayered ePTFE implant is well tolerated and promotes tissue integration, supporting tissue-integrated filtration as a potentially more effective glaucoma surgery.
Related
- A Novel Reversible Tube Ligation Technique for Managing Hypotony After Paul Glaucoma Implant Surgery in Uveitic Glaucoma.
- Case Report: Successful needle revision of an encapsulated bleb following PAUL glaucoma Implant surgery in a pediatric patient
- Extension of a Severed Paul Glaucoma Implant Tube Using the Crawford Lacrimal Tube: A Novel Surgical Technique.
- Anatomopathological Aspects and Clinical Correlation of Conjunctival Bleb Fibrosis Following Encapsulation of a Biodegradable Collagen Matrix Implant in Glaucoma Surgery
- The Paul Glaucoma Implant versus the Ahmed and Baerveldt Glaucoma Implants: A Systematic Review and Bayesian Network Meta-Analysis.
BibTeX
@article{pitha2026sixmonth,
title = {{Six-Month Preclinical Evaluation of a Bilayered ePTFE Glaucoma Implant in Normotensive Rabbits}},
author = {Ian Pitha and Charissa Tan and Lieu Nguyen Lowrie and Evan Conrad and Meghan Sharma and Michael Jensen and Austin Nakatsuka and James Stanley and Paul Goodman and Kevin Savory and Iqbal Ike K Ahmed},
journal = {Translational Vision Science \& Technology},
year = {2026},
month = oct,
doi = {10.1167/tvst.15.10.35},
url = {https://doi.org/10.1167/tvst.15.10.35},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Six-Month Preclinical Evaluation of a Bilayered ePTFE Glaucoma Implant in Normotensive Rabbits
AU - Ian Pitha
AU - Charissa Tan
AU - Lieu Nguyen Lowrie
AU - Evan Conrad
AU - Meghan Sharma
AU - Michael Jensen
AU - Austin Nakatsuka
AU - James Stanley
AU - Paul Goodman
AU - Kevin Savory
AU - Iqbal Ike K Ahmed
PY - 2026
DA - 2026/10/23
JO - Translational Vision Science & Technology
DO - 10.1167/tvst.15.10.35
UR - https://doi.org/10.1167/tvst.15.10.35
AB - Purpose: The efficacy of intraocular pressure (IOP)-lowering glaucoma surgery is limited by postoperative fibrosis. A bilayered expanded polytetrafluoroethylene (ePTFE) implant reduced fibrosis compared with silicone controls in a three-month study in normotensive rabbit eyes. Here, we evaluate biocompatibility and histopathology over six months. Methods: Twelve normotensive New Zealand white rabbits underwent bilayered ePTFE implantation in one eye and a sham procedure in the fellow eye. Clinical exams were monitored serially over six months and graded, including gross inspection, slit-lamp biomicroscopy, bleb evaluation, IOP measurement, and fundus examination. After six months, histopathologic analysis was performed on six eyes and graded for cellular integration, fibrosis, and inflammation. Results: The implant was well tolerated. No significant differences in conjunctival hyperemia or bleb vascularity were observed between implant and sham eyes; however, tube position was closer to the cornea at six months. In implanted eyes, IOP was reduced at postoperative day 1 (12.4 ± 1.6 mm Hg, P = 0.001), week 1 (12.7 ± 1.9 mm Hg, P = 0.006), week 2 (12.9 ± 2.0 mm Hg, P = 0.002), month 1 (13.1 ± 1.5 mm Hg, P = 0.01), and month 3 (14.1 ± 2.1 mm Hg, P = 0.04) versus baseline (16.5 ± 2.9 mm Hg). Sham eyes showed reductions at day 3 and week 2. Histopathology demonstrated cellular integration into the outer ePTFE layer, with minimal inflammation (0.9 ± 1) and fibrosis (1.1 ± 0.2). Conclusions: A bilayered ePTFE glaucoma implant was well tolerated for six months, with minimal inflammation or fibrosis. Translational Relevance: A low-profile, bilayered ePTFE implant is well tolerated and promotes tissue integration, supporting tissue-integrated filtration as a potentially more effective glaucoma surgery.
SN - 2164-2591
ER -